Published in Vestn Otorinolaringol on May 24, 1984
[Effects of carnosine on systemic hemodynamics and myocardial metabolism in rats in the early postresuscitation period]. Biull Eksp Biol Med (1992) 0.78
[Prevention of impairment of myocardium metabolism and function in immobilization stress using previous adaptation to short stress exposures]. Vopr Med Khim (1985) 0.77
Effect of hypoxia on metabolism and contractile function of the heart in rats with type 2 diabetes mellitus and abdominal obesity. Bull Exp Biol Med (2004) 0.76
[Reperfusion injury of myocardial biomembranes after acute fatal hemorrhage and their correction with carnosine]. Biokhimiia (1992) 0.75
[Diastolic malfunction in sepsis and septic shock]. Anesteziol Reanimatol (2004) 0.75
[Total sequestration of the labyrinth]. Vestn Otorinolaringol (1992) 0.75
[Preventive strategy for atrial fibrillation in arterial hypertension]. Klin Med (Mosk) (2009) 0.75
[Disorders of cardiac contractility caused by hemorrhagic hypotension]. Anesteziol Reanimatol (2000) 0.75
[Clinical significance of the parameters of a systemic inflammatory response, leukocytic intoxication index, and procalcitonin test in the diagnosis of pyodestructive pyelonephritis of pregnant women]. Anesteziol Reanimatol (2008) 0.75
[Prevention of heart damage of sodium oxybutyrate in terminal states caused by acute blood loss]. Kardiologiia (1982) 0.75
[Disorders of purine metabolism in patients with peritonitis complicated by sepsis]. Anesteziol Reanimatol (2000) 0.75
[Use of inderal for preventing heart damage in mechanical asphyxia accompanied by clinical death]. Patol Fiziol Eksp Ter (1985) 0.75
[Quercetin as an agent to prevent the cardiotoxic action of antituberculosis preparations]. Patol Fiziol Eksp Ter (1986) 0.75
[The use of carnosine for reducing the post-resuscitation damage to the heart following acute fatal blood loss]. Anesteziol Reanimatol (1992) 0.75
[Iron metabolism and its role in traumatic disease]. Anesteziol Reanimatol (2014) 0.75
[Use of the synthetic antioxidant ionol for prevention of post-resuscitation myocardial damage]. Anesteziol Reanimatol (1984) 0.75
[Structural basis of impairment of the external respiratory function in the post-resuscitation period]. Arkh Patol (1987) 0.75
[Effect of acute fatal blood loss on peroxidation of myocardial lipids during the postresuscitation period]. Vopr Med Khim (1988) 0.75
[Prevention of functional and metabolic cardiac disorders in acute blood loss with gutimin]. Patol Fiziol Eksp Ter (1986) 0.75
[Systemic inflammation complication of acute coronary syndrome with diabetes mellitua type 2]. Patol Fiziol Eksp Ter (2011) 0.75
[Impaired blood coagulative properties in the early postresuscitation period and their prevention]. Anesteziol Reanimatol (2005) 0.75
[Peculiarities of lower limb varicosity in patients with various levels of functioning of the cardiovascular system]. Angiol Sosud Khir (2007) 0.75
[Effects of clinical death and pre-administered inderal on adrenoreactivity of the heart in post-resuscitation period]. Biull Eksp Biol Med (1990) 0.75
Amylolytic activity of small intestinal brush-border membrane in the late postresuscitation period. Bull Exp Biol Med (2004) 0.75
[Fatal acute hemorrhage and activity of serum and erythrocyte cholinesterase]. Anesteziol Reanimatol (1997) 0.75
[Effect of early post-resuscitation endotoxemia on the myocardial function]. Anesteziol Reanimatol (2004) 0.75
[Use of sodium gamma-hydroxybutyrate to prevent heart damage in acute fatal blood loss]. Anesteziol Reanimatol (1983) 0.75
[Ionol as a drug for the prevention of cardiotoxic effect of antitubercular agents]. Probl Tuberk (1984) 0.75
[The effect of preliminary administration of the beta-blocker inderal on the course of the postresuscitation period]. Anesteziol Reanimatol (1990) 0.75
[Hemodynamic disorders and myocrdial insufficiency after toxic doses of propranolol]. Vestn Ross Akad Med Nauk (2011) 0.75
[Isoptin in the prevention of post-resuscitation damage of the heart]. Patol Fiziol Eksp Ter (1987) 0.75
[Inderal as an agent for preventing postresuscitation heart injuries]. Patol Fiziol Eksp Ter (1989) 0.75
[The antioxidant hydroxypyridine-6 as an agent to prevent postresuscitation heart damage]. Patol Fiziol Eksp Ter (1992) 0.75
[Changes in coagulation hemostasis in patients after coronary bypass surgery]. Klin Lab Diagn (2008) 0.75
[The membrane-protective effect of carnosine in the post-resuscitation period after acute lethal blood loss]. Vopr Med Khim (1993) 0.75
[Comparative evaluation of different infusion medias used in therapy for neonatal hypovolemia]. Anesteziol Reanimatol (2005) 0.75
[Role of disorders of metabolism in rat myocardium and endotoxemia in the pathogenesis of post-resuscitation cardiodepression]. Patol Fiziol Eksp Ter (1999) 0.75
[Prevention of postresuscitation heart failure by using ionol]. Biull Eksp Biol Med (1983) 0.75
Heart sensitivity to electrolyte composition of perfusion solution of rats after severe brain injury. Bull Exp Biol Med (2006) 0.75
Experimental model of heart contusion. Bull Exp Biol Med (2009) 0.75
[The effect of acute fatal blood loss on post-resuscitation changes in heart phospholipids and prevention of them]. Vopr Med Khim (1991) 0.75
[The pathogenesis and correction of disorders of the heart rhythm in the early post-resuscitation period]. Anesteziol Reanimatol (1993) 0.75
[Prophylaxis of acute pancreatitis during resection of the stomach for "difficult" complicated of duodenal ulcers]. Vestn Khir Im I I Grek (2009) 0.75
[Critical conditions as a logical and appropriate series of events in iron methabolism disorders (the summary of experimental studies)]. Biomed Khim (2014) 0.75
[Immunological aspects of postresuscitation damage to the myocardium]. Patol Fiziol Eksp Ter (1987) 0.75
[Clinical management of disorders hemostasis-related with obstetric complications]. Vestn Ross Akad Med Nauk (2014) 0.75
[Antioxidant ionol as an agent preventing post-resuscitation cardiac insufficiency]. Patol Fiziol Eksp Ter (1984) 0.75
[Cardiac damage and protection in acute fatal blood loss]. Vestn Ross Akad Med Nauk (2002) 0.75
[The clinical significance of matrix metalloproteases in heart and vascular pathology]. Patol Fiziol Eksp Ter (2013) 0.75
[Study of pathogenesis of Anaprilin toxicological influence in analysis of central hemodynamic indices and myocardial contractility of isolated heart in experiment]. Patol Fiziol Eksp Ter (2012) 0.75
[Principle energy substrate changing as a technique of myocardium protection against ischemic damage in experimental mechanic cardiac contusion]. Patol Fiziol Eksp Ter (2009) 0.75
[The participation of matrix metalloproteinases-9 and TIMP-1 in formation of atrial fibrillation paroxisms in patients with metabolic syndrome]. Patol Fiziol Eksp Ter (2014) 0.75
[Clinical effects of packed red blood cells transfusion according to storage life and time of transfusion]. Khirurgiia (Mosk) (2014) 0.75
[Possibilities of impedance tests in perforative otitis media]. Vestn Otorinolaringol (1984) 0.75
[Arrest of the chronic pain syndrome using epidural analgesia in patients with disseminated prostate cancer]. Anesteziol Reanimatol (2003) 0.75
[Use of the antioxidant ionol to prevent damage to the heart from prolonged administration of antitubercular preparations]. Biull Eksp Biol Med (1983) 0.75
[Effect of acute fatal blood loss on the functional metabolic disturbances of the heart in the postresuscitation period]. Anesteziol Reanimatol (1989) 0.75
[Iron metabolism in biological systems (biochemical, pathophysiological and clinical aspects)]. Biomed Khim (2007) 0.75
[Immune disturbances in patients with postnecrotic pseudocysts of the pancreas]. Antibiot Khimioter (2012) 0.75
[Disordered cardiac contractility after clinical death caused by acute blood loss]. Anesteziol Reanimatol (1997) 0.75
[Effectiveness of oxygen therapy for pulmonary edema in patients with hypertensive crisis before hospitalization]. Anesteziol Reanimatol (2003) 0.75
[Problem of intraoperative hemotransfusion]. Anesteziol Reanimatol (2014) 0.75
[Myocardial contractility after brain injury]. Anesteziol Reanimatol (2006) 0.75
[Prevention of postresuscitation heart damage with gutimine]. Anesteziol Reanimatol (1987) 0.75
[Prevention of post-resuscitation metabolic disorders by the antioxidant oxypyridine-6]. Vopr Med Khim (1992) 0.75
[Endotoxemia in hemorrhagic hypotension]. Patol Fiziol Eksp Ter (2009) 0.75
Ultrasonic model of acute pancreatitis. Bull Exp Biol Med (2005) 0.75
[Influence of heptral on the functional-metabolic indices of the liver of rats with necrotizing pancreatitis]. Patol Fiziol Eksp Ter (2013) 0.75
[Usefulness of tympanometry in imperforate otitis media]. Vestn Otorinolaringol (1983) 0.75
[Use of neoton and finoptin to correct metabolic disorders of the brain in craniocerebral injuries]. Anesteziol Reanimatol (1999) 0.75
[Use of plasmapheresis for correction of metabolic disorders in patients with surgical sepsis]. Anesteziol Reanimatol (2001) 0.75
[Inderal as a means of preventing damage to vitally important organs in the case of mechanical asphyxiation, accompanied by clinical death]. Anesteziol Reanimatol (1989) 0.75
[The matrix metalloproteinase 9 (MMP-9) and TIMP-1 activities in patients with chronic and recurrent pancreatitis]. Eksp Klin Gastroenterol (2010) 0.75
[Prognostic value of determining the succinate dehydrogenase activity of lymphocytes and the therapeutic effectiveness of sodium succinate in resuscitation of rats]. Biull Eksp Biol Med (1985) 0.75
[A cerebral hernia of the postoperative mastoidal cavity (current aspects of the problem)]. Vestn Otorinolaringol (1990) 0.75
[Use of isoptin in the prevention of post-resuscitation heart damage]. Anesteziol Reanimatol (1987) 0.75
[The use of sodium gamma-oxybutyrate and gutimine for decreasing metabolic disorders in the heart, caused by exotoxic shock in acetic acid poisoning]. Vopr Med Khim (1994) 0.75
[Efficacy of ivabradine in combination therapy for complicated acute coronary syndrome in patients with type 2 diabetes mellitus]. Ter Arkh (2010) 0.75
[Prevention with inderal of post-resuscitation impairment of metabolism in heart and brain tissues]. Vopr Med Khim (1990) 0.75
[Atrial fibrillation and condition of vegetative nervous system: features of tactics and medical aid rendering at the pre-hospital stage]. Patol Fiziol Eksp Ter (2015) 0.75
[Introduction of new technologies in teaching basic and clinical pathophysiology]. Patol Fiziol Eksp Ter (2008) 0.75
[The verapamil correction of postresuscitation damages to the heart]. Anesteziol Reanimatol (1997) 0.75
[Effects of immunocorrective therapy on immunological indices in patients with chronic bacterial prostatitis]. Urologiia (2012) 0.75
[Drainage of the pancreatic duct]. Vestn Khir Im I I Grek (2006) 0.75
[Activation of lipid peroxidation and its prevention with ionol during mechanical asphyxia followed by resuscitation]. Biull Eksp Biol Med (1983) 0.75
[Inventions in otorhinolaryngology (a survey of patent information 1974-1980)]. Vestn Otorinolaringol (1982) 0.75
[Use of quercetin to prevent and treat cardiovascular disorders in pulmonary tuberculosis]. Probl Tuberk (1986) 0.75
[Use of succinate dehydrogenase activity of lymphocytes to predict the course of the post-resuscitation period]. Biull Eksp Biol Med (1985) 0.75
[Prevention of post-resuscitation impairment of energy metabolism in the myocardium using sodium gamma-hydroxybutyrate, ionol and gutimine]. Vopr Med Khim (1988) 0.75
[Genesis of systemic changes in hemodynamics in cardiac contusion]. Anesteziol Reanimatol (2009) 0.75
[The antioxidant oxypyridine-6 as an agent for preventing postresuscitation functional metabolic damage to the heart]. Anesteziol Reanimatol (1991) 0.75
[Complex prevention of thrombotic complications in patients with colorectal cancer during different stages of surgical treatment]. Anesteziol Reanimatol (2001) 0.75
[Impact of postoperative early enteral feeding on hemodynamics, oxygen and nutritive status in patients with colonic malignancies concurrent with type 2 diabetes mellitus]. Anesteziol Reanimatol (2008) 0.75
[Treatment of patients with purulent wound infection under conditions of extreme north]. Vestn Khir Im I I Grek (2009) 0.75
[Cardioprotective effect of exogenous creatine phosphate in acute hemorrhage]. Anesteziol Reanimatol (2003) 0.75
[Activation of lipid peroxidation processes in the postresuscitation period]. Anesteziol Reanimatol (1988) 0.75
[Can one study pathological physiology independently according to an individual plan?]. Patol Fiziol Eksp Ter (1991) 0.75
[Treatment for urologic polyneoplasia]. Vopr Onkol (2008) 0.75
[Immunologic aspects of myocardial damage during long-term administration of antitubercular preparations]. Probl Tuberk (1983) 0.75
[Iron metabolism disturbance as a marker of the illness severity in the intensive care kind of patients]. Fiziol Cheloveka (2007) 0.75